Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes

N Z Med J. 1997 May 23;110(1044):189-90.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 2 / complications*
  • Female
  • Gliclazide / adverse effects*
  • Hormones / therapeutic use*
  • Humans
  • Hypoglycemia / chemically induced*
  • Hypoglycemic Agents / adverse effects*
  • Middle Aged
  • Octreotide / therapeutic use*

Substances

  • Blood Glucose
  • Hormones
  • Hypoglycemic Agents
  • Gliclazide
  • Octreotide